Dermatology and Hair Restoration: Who Treats What in 2026

Introduction: The Hidden Gap Between Diagnosis and Surgery

Patients who search “dermatologist vs. hair transplant surgeon” usually expect a simple answer. What they typically find is the same generic framing repeated across dozens of websites: dermatologists handle early hair loss, and surgeons handle advanced cases. That framing is not wrong, but it leaves out the most important part of the story.

Dermatology residency rigorously trains physicians to diagnose hair loss. Hair restoration surgery has no equivalent standard. There is no ABMS-recognized board certification for hair restoration surgery, which means any licensed physician can legally perform hair transplants regardless of training.

This article provides a clear decision map. It shows when a dermatology visit is necessary, when it is not enough on its own, and why an integrated model, combining careful diagnosis with board-certified surgical expertise, resolves much of the confusion.

The stakes are real. The International Society of Hair Restoration Surgery (ISHRS) 2025 Practice Census documents rising repair cases and a growing number of black-market clinics. Meanwhile, only about 270 surgeons worldwide hold Diplomate status with the American Board of Hair Restoration Surgery (ABHRS). Most patients have no idea this credential gap exists.

Beyond “Dermatologist vs. Surgeon”: Understanding the Actual Regulatory Divide

The true distinction is not one specialty versus another. It is the difference between being trained to diagnose and being trained to operate, and U.S. medical regulation treats these two things very differently.

Any physician with a general medical license can legally perform hair transplant surgery. No hair-specific training, residency, or board exam is required. Dermatology, by contrast, follows a structured residency pathway that mandates extensive training in diagnosing conditions of the skin, hair, and nails.

What Dermatology Residency Actually Trains For

Dermatologists are trained to use a detailed diagnostic toolkit when evaluating hair loss:

• Patient history, including family patterns, medications, stress, diet, and recent illness
• Scalp examination to assess pattern, density, and signs of inflammation
• Pull tests to gauge active shedding
• Trichoscopy, a magnified examination of hair shafts and follicles
• Bloodwork to check thyroid function, iron levels, and hormones
• Scalp biopsy when the diagnosis is uncertain

Dermatology training also covers an enormous range of conditions beyond hair, including skin cancer, eczema, psoriasis, and acne. As a result, hair-specific cases are often a small fraction of a general dermatologist’s daily practice.

Even so, the American Academy of Dermatology notes that dermatologists have expertise in diagnosing hair loss and counseling patients on what may help them regrow hair. They are widely recognized as the appropriate first point of contact for determining the cause.

The Surprising Regulatory Gap: Licensed Doesn’t Mean Trained

No ABMS-recognized board certification exists specifically for hair restoration surgery. The American Board of Hair Restoration Surgery is the only certification dedicated to hair transplant surgery, but it is not recognized by the ABMS. Only about 270 surgeons worldwide hold ABHRS Diplomate status, compared with more than 1,200 ISHRS members.

The practical consequence is significant. A physician from any background, even one entirely unrelated to dermatology or surgery, can legally advertise and perform hair transplants.

What Dermatologists Are Equipped to Diagnose and Treat

Androgenetic alopecia (AGA), commonly called pattern hair loss, is the most frequent diagnosis. According to research published in PLOS ONE, up to 80% of men and 50% of women develop AGA by age 70. The ISHRS 2025 Practice Census found AGA was the primary cause of loss in 70.9% of surgical hair restoration patients.

A meaningful share of cases, however, are driven by something else entirely. Dermatologists are trained to catch conditions that mimic or coexist with AGA, including:

• Telogen effluvium, a temporary shedding triggered by stress, illness, or surgery
• Scalp psoriasis and seborrheic dermatitis
• Thyroid disease
• Polycystic ovary syndrome (PCOS)
• Iron deficiency

Dermatologists also diagnose scarring (cicatricial) alopecias, such as lichen planopilaris, frontal fibrosing alopecia, and discoid lupus. These conditions require medical management of inflammation before a transplant can be safely considered, and in some cases instead of a transplant altogether.

For first-line medical management, only two medications are FDA-approved specifically for pattern hair loss:

1. Topical minoxidil, approved for both men and women
2. Oral finasteride, approved for men only

The Cleveland Clinic describes these as first-line treatments for male pattern hair loss, with topical minoxidil serving as the first-line option for female pattern hair loss. Both are typically prescribed and monitored before, during, and after any surgical intervention, because a transplant does not stop ongoing genetic hair loss.

Where Dermatology Stops: Why Diagnosis Alone Isn’t Enough

Most general dermatologists diagnose and manage hair loss medically but do not perform transplant surgery themselves. When surgery becomes appropriate, they refer out.

Referral alone creates a gap. Patients are sent into a market with no mandatory hair-specific surgical credential and are left to vet surgical qualifications on their own. Many assume that any physician offering transplants has specialized training, but nothing in the regulatory structure guarantees it.

This is where the ABHRS scarcity becomes particularly important. With only about 270 Diplomates worldwide, true surgical specialization is rare. It also means “board-certified” claims can be misleading. A physician may be board-certified in a field such as family medicine or emergency medicine, which is legitimate, but that certification says nothing about hair restoration skill.

The Data Behind the Gap: What the ISHRS 2025 Practice Census Reveals

The ISHRS 2025 Practice Census, which reports data from 2024, puts hard numbers behind these concerns.

• Black-market clinics are spreading. In 2024, 59% of ISHRS members reported unregulated hair transplant clinics operating in their cities, up from 51% in 2021.
• Repair cases are rising. Repairs of botched procedures accounted for 6.9% of all transplants in 2024, a 28% relative increase from 2021. That figure is direct evidence of harm caused by unqualified providers.
• Patients are getting younger. Ninety-five percent of first-time surgical patients in 2024 were between ages 20 and 35. Younger patients face decades of potential future loss, which makes lifetime treatment planning, careful donor management, and ongoing medical therapy essential.
• More women are seeking treatment. Female surgical patients grew 16.5% between 2021 and 2024 and now represent 15.3% of surgical patients. Women make up 38.3% of nonsurgical treatment patients. Because women more often experience diffuse thinning, a diagnosis-first approach matters even more.
• FUE is the standard technique. Follicular unit extraction accounts for roughly 80% of global procedures, with an average of about 2,347 grafts for a first procedure. This offers useful context for what standard-of-care surgery looks like today.

The Decision Map: Where to Go Based on Your Situation

The flat advice to “see a dermatologist first, then a surgeon” does not account for how different each patient’s situation can be. The following scenario-based guide offers a more practical approach.

Scenario 1: Early or Unclear Hair Thinning

A dermatologic evaluation should come first. The goal is to rule out thyroid disease, iron deficiency, telogen effluvium, and other non-AGA causes.

Skipping this step carries real risk. If the root cause is not androgenic, a transplant may be unnecessary, or it may fail because the underlying problem continues to drive hair loss.

Scenario 2: Inflammatory or Scarring Alopecia Symptoms

Symptoms such as itching, burning, redness, scaling around follicles, or a receding hairline with shiny skin can signal conditions like lichen planopilaris or frontal fibrosing alopecia. These must be medically controlled before any transplant is considered.

Active inflammation can destroy transplanted grafts. In these cases, dermatologic management is a prerequisite to surgery, not an alternative to it. Many patients require a sustained period of stable, inactive disease before a surgeon will even evaluate candidacy.

Scenario 3: Confirmed Androgenetic Alopecia and Surgical Candidacy

The ideal path looks like this: diagnosis confirms AGA as the driver, medical management has plateaued or is not sufficient on its own, and the patient is then evaluated for surgical candidacy based on donor supply, pattern of loss, age, and expectations.

This is where credential scrutiny matters most. Patients should verify hair-restoration-specific training, such as ABHRS Diplomate status or documented specialization, rather than assuming any licensed physician is equally qualified.

Scenario 4: Female Pattern Hair Loss

Women more commonly experience diffuse thinning across the top of the scalp rather than distinct bald areas. Diffuse loss often affects the donor area too, which limits surgical options. For many women, nonsurgical management, including minoxidil, platelet-rich plasma (PRP), and low-level light therapy, is the better starting point.

The ISHRS data reflects this: women represent 38.3% of nonsurgical patients but only 15.3% of surgical patients. That gap reinforces the need for a careful, diagnosis-first approach rather than a surgery-first sales pitch. Some women with stable, well-defined loss are excellent surgical candidates, but that determination should follow a thorough workup.

Scenario 5: Patients with Skin of Color or Ambiguous Scalp Symptoms

Misdiagnosis is a documented risk. A systematic review in the International Journal of Dermatology, reported by AJMC, found that over half of hair and scalp disorder cases in patients with skin of color were initially misdiagnosed, and scalp biopsy corrected the diagnosis in 50% of those cases.

For these patients, and for anyone with unusual or ambiguous symptoms, a thorough dermatologic workup is essential before pursuing any surgical option. A cosmetic consultation alone is not enough.

Why an Integrated Model Closes the Gap in Care

The core structural problem is coordination. Most patients are bounced between a dermatologist, who provides diagnosis only, and a surgical provider whose training may be unverified. The two rarely communicate, and the patient carries the burden of connecting the dots.

An integrated model, with thorough diagnostic evaluation and board-certified surgical expertise under one roof, directly solves this disconnect.

There is strong historical precedent for this approach. Dermatology and hair restoration have always been intertwined. Dr. Bobby Limmer, a dermatologist, pioneered the modern FUT (strip) technique using microscopic dissection in the early 1990s. The fields were never meant to be fully separate.

An integrated model allows continuous oversight across the entire journey:

• Before surgery: medical management to stabilize loss and identify contributing conditions
• At evaluation: an honest assessment of surgical candidacy, including whether surgery is the right choice at all
• After transplantation: ongoing follow-up for conditions that could affect graft survival or long-term hair health

What This Looks Like in Practice

At Hair Transplant Specialists in Eagan, Minnesota, the team combines deep hair-loss expertise with board-certified surgical specialization. Dr. Sharon Keene, a former President of the ISHRS, brings extensive experience in both surgical and non-surgical hair loss treatment, along with a research record that includes work on vitamin D deficiency and hair loss, photobiomodulation, and safe FUE excision limits. Board-certified surgeons Dr. Roy Stoller, an examiner for board certification exams, and Dr. Paul Rose round out a team with more than 100 combined years of practice.

This structure allows diagnosis, medical management, and surgery to happen within one coordinated patient journey. It reduces the risk of patients falling into the regulatory gap and being operated on by a physician without dedicated hair restoration training.

It also means techniques like FUE and FUT, including the practice’s proprietary Microprecision Follicular Grafting® technique used in its FUT procedures, are performed by surgeons with documented specialization. This stands in contrast to general practitioners expanding into cosmetic procedures without oversight.

Questions to Ask Any Provider Before Committing to Treatment

Patients evaluating any practice can use this checklist:

1. How was the diagnosis made? Was it based on trichoscopy, bloodwork, or biopsy, or only a visual assessment?
2. Who will perform the procedure? Does the surgeon hold ABHRS Diplomate status or equivalent documented hair-restoration-specific training? Will that surgeon personally perform the critical steps?
3. Have nonsurgical options been considered? Were minoxidil, finasteride, PRP, or low-level light therapy properly trialed or ruled out before surgery was recommended?
4. What happens if a medical condition is discovered? If scarring alopecia, thyroid issues, or another condition surfaces, does the practice manage it in-house or coordinate care, or does it simply proceed to surgery?
5. What is the long-term plan? Especially for younger patients, how will the practice account for future hair loss?

Verifying credentials matters far more than marketing claims. With black-market clinics reported in 59% of ISHRS members’ cities, these questions are a patient’s best protection.

Conclusion: Closing the Gap Between Diagnosis and Treatment

Dermatology and hair restoration surgery are not interchangeable. Because there is no ABMS-recognized certification for hair restoration surgery, patients must take an active role in verifying provider qualifications.

The decision map is straightforward: dermatologic evaluation for diagnosis and medical management, verified surgical specialization for transplant procedures, and both working together for the best outcomes. An integrated model, with diagnosis and board-certified surgical expertise under one roof, directly addresses the risks highlighted by the ISHRS 2025 Practice Census, including rising repair cases and the growth of black-market clinics.

Take the Next Step With an Integrated Hair Restoration Team

Hair Transplant Specialists offers consultations that begin with a careful, diagnosis-focused evaluation rather than a sales-driven surgical pitch. The team’s ISHRS leadership background, board-certified surgeons, and decades of combined experience reflect the integrated approach described throughout this article.

Readers are encouraged to bring the questions and decision map above to any consultation, including one with Hair Transplant Specialists. The practice is built to meet that standard.

To schedule a personalized evaluation, call (651) 393-5399 or visit INeedMoreHair.com. The Eagan office is open Monday through Thursday from 9:00 AM to 5:00 PM, Friday from 9:00 AM to 3:00 PM, and weekends by appointment.